Cytomegalovirus and multiple sclerosis risk

Journal of Neurology

Volumn 260, Issue 6, 2013, Pages 1658-1660

  Pakpoor, Julia ^a   Pakpoor, Jina ^b   Disanto, Giulio ^a   Giovannoni, Gavin ^c   Ramagopalan, Sreeram V ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

CYTOMEGALOVIRUS INFECTIONS; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 84878851197     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6912-4     Document Type: Letter

References (18)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343(13):938-952
2. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61(4):288-299 (Pubitemid 46676728)
3. Zivadinov R, Nasuelli D, Tommasi MA et al (2006) Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 28(3):262-269 (Pubitemid 43765110)
4. Ascherio A, Munger KL, Lennette ET et al (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286(24):3083-3088 (Pubitemid 34016522)
5. Buljevac D, van Doornum GJ, Flach HZ et al (2005) Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 76(10):1377-1381 (Pubitemid 41360975)
6. Coyle PK, Sibony PA (1987) Viral specificity of multiple sclerosis tear immunoglobulins. J Neuroimmunol 14(2):197-203 (Pubitemid 17018122)
7. Höllsberg P, Hansen HJ, Haahr S (2003) Altered CD8 + T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol 132(1):137-143 (Pubitemid 36418916)
8. Hopkins RS, Indian RW, Pinnow E, Conomy J (1991) Multiple sclerosis in Galion, Ohio: prevalence and results of a case-control study. Neuroepidemiology 10(4):192-199
9. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 67(6):824-830
10. Martínez-Rodríguez JE, Saez-Borderías A, Munteis E, Romo N, Roquer J, López-Botet M (2010) Natural killer receptors distribution in multiple sclerosis: relation to clinical course and interferon-beta therapy. Clin Immunol 137(1):41-50
11. Myhr KM, Riise T, Barrett-Connor E et al (1998) Altered antibody pattern to Epstein-Barr virus but not to other herpes viruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 64(4):539-542 (Pubitemid 28195960)
12. Pandit L, Malli C, D'Cunha A, Shetty R, Singhal B (2013) Association of Epstein-Barr virus infection with multiple sclerosis in India 325(1-2):86-89
13. Provinciali L, Laurenzi MA, Vesprini L et al (1988) Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand 78(6):449-454 (Pubitemid 19017782)
14. Sanadgol N, Ramroodi N, Ahmadi GA et al (2011) Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis. New Microbiol 34(3):263-274
15. Vartdal F, Vandvik B, Norrby E (1980) Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 8(3):248-255 (Pubitemid 10018372)
16. Wandinger K, Jabs W, Siekhaus A et al (2000) Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55(2):178-184 (Pubitemid 30604615)
17. Jafari N, Melles DC, Broer L, van Duijn CM, van Doornum GJJ, Hintzen RQ (2011) Higher EBV anti-early antigen IgG titres in MS patients of a Dutch genetic isolate: genes or environment? Data presented at the 5th Joint triennial congress of the European and American Committees for treatment and research in multiple sclerosis, Amsterdam, The Netherlands, 19-22 Oct 2011
18. DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A (2006) Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63(6):839-844 (Pubitemid 43882291)